Article Name Medtech

Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity

Clinical Advancements in Obesity Treatment: Innovent Biologics Initiates Phase 3 Trial of Mazdutide

02nd January, 2024


Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform

Strategic Acquisition Unveiled: Roche Enhances Point of Care Diagnostics with LumiraDx Technology

01st January, 2024


Health On Cloud Expands Global Presence with Innovative Metaverse Medical Platform

Transforming Healthcare Globally: Health On Cloud's Metaverse Initiative

29th December, 2023


Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Pioneering Atrial Fibrillation Treatment: AVANT GUARD Trial Advances FARAPULSE™ PFA System

29th December, 2023


MedTech Marvels 2024: 24 MedTech Trends to Watch in 2024

Exploring Cutting-Edge Trends and Key Players in the Dynamic Landscape of Medical Technology

29th December, 2023


Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024

Revolutionizing Healthcare with HYLA™ Blood Sensor: A Game-Changer for Continuous Blood Monitoring

28th December, 2023


IIT-M develops 3D-printed face implants for patients suffering from Black Fungus

In partnership with Chennai-based Zoriox Innovation Labs

27th December, 2023


Government unveils MedTech Mitra platform to empower innovators and advance healthcare solutions

MedTech Mitra is a platform for budding entrepreneurs and innovators in India: Prof. S.P Singh Bhagel

27th December, 2023


HiMedia’s COVID-19 PCR Kit detects the JN.1 variant

HiMedia Laboratories announces that its RT-PCR kits are capable of detecting the recently discovered JN.1, SARS-CoV-2 variant.

26th December, 2023


BlueWind Medical Brings Revi Implantable Tibial Neuromodulation Device to Patients

Patients in the tri-state region of Louisiana, Arkansas, and Texas can now benefit from the first FDA marketing authorized, battery-free tibial neuromodulation implant for patients with Urge Urinary Incontinence

22nd December, 2023


BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial

Promising Anti-TIM-3 Monoclonal Antibody Shows Potential for Addressing High Unmet Medical Need in Liver Cancer

21st December, 2023


Volpara Health breast density and mammography quality software highlighted in new peer-reviewed research

Volpara Analytics uses AI to measure mammography positioning, compression, and dose

21st December, 2023


Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline

Everest Medicines' Licensing Partner, Calliditas Therapeutics, achieves significant milestone with FDA's complete approval of Nefecon®.

21st December, 2023


Revealing the Detailed Structure of Lipids and Other Biological Compounds, Contributing to the Development of Health Care and the Life Sciences

Release of the OAD-TOF System, the First in the World to Provide Chemical Structural Analysis

21st December, 2023


American Oncology Institute (AOI) at Nangia Specialty Hospital in Nagpur Launches Specialized Lung Cancer Unit for Comprehensive Care and Early Diagnosis

AOI Nangia Specialty Hospital in Nagpur Unveils State-of-the-Art Lung Cancer Unit for Personalized and Comprehensive Patient Care

20th December, 2023


Wockhardt Hospitals, Mumbai Central to become a first hospital in Mumbai to introduce millet-based food diet for patients

Wockhardt Hospitals, in association with Sodexo introduces a healthy millet based diet for its patients under the initiative named ’Arogyam’ at its Sobo hospital

20th December, 2023


Japan's Terumo introduces drug-eluting stent for treatment of coronary artery disease in India

Drug-eluting stent has evolved to become a preferred option for heart related treatments

19th December, 2023


MedTech firm Biorithm secures $3.5M in Series A funding to advance maternal care globally

Series A funding to fortify US market entry and growth strategy, as well as pursue breakthrough research

18th December, 2023


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer